Pomelo Care Pulls In $92M Series C Round
2026-01-08
NEW YORK, NY, Today, Pomelo Care, the national leader in evidence-based healthcare for women and children, announced it has raised $92 million in Series C funding.
The round was led by Stripes with participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, and SV Angel. Valued at $1.7 billion, Pomelo enters its next chapter after proving that its virtual maternity care model measurably reduces preterm births, NICU admissions, and medical costs at scale. Now supporting nearly 7% of all U.S. births, the company is expanding beyond maternity to bring its proven model to women and children throughout their lives-closing gaps in access and quality, lowering costs, and setting a new national standard for women's and children's healthcare.
Pomelo Care is the national leader in evidence-based healthcare for women and children. We deliver personalized, high-quality clinical interventions from reproductive care and pregnancy, infant care and pediatrics, to hormonal health through perimenopause and menopause, with long-term preventive care and condition management. Our model delivers 24/7 multispecialty care to address the medical, behavioral, and social factors that most significantly impact outcomes for women and children. We partner with payers, employers, and providers to expand access to quality healthcare across the system.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors